Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors
Clinical trial NCT01877811 · COMPLETED
Trial details
- NCT number
- NCT01877811
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2018-12-01
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.